Advertisement
Screener

COCRYSTAL PHARMA, INC. (COCP) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.2 / 5 stars · 14/60 Roast Me

COCRYSTAL PHARMA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

COCRYSTAL PHARMA, INC. (COCP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.36 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13

  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.14M shares, a 1055.97% increase year-over-year.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 704.00K shares, a 26.16% increase year-over-year.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 558.00K shares, a 53.72% increase year-over-year.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 363.00K shares, a 60.62% increase year-over-year.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.86M shares, a 1000.42% increase from fiscal 2024.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 714.00K shares, a 25.48% increase from fiscal 2023.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 569.00K shares, a 56.75% increase from fiscal 2022.
  • COCRYSTAL PHARMA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 363.00K shares, a 60.62% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-308.36M shares
10-Q · filed 2026-08-13
2026-03-318.14M shares
10-Q · filed 2026-05-15
2025-12-317.86M shares
10-K · filed 2026-03-31
2025-09-306.50M shares
10-Q · filed 2025-11-14
2025-06-30692.00K shares
10-Q · filed 2026-08-13
2025-03-31704.00K shares
10-Q · filed 2026-05-15
2024-12-31714.00K shares
10-K · filed 2026-03-31
2024-09-30811.00K shares
10-Q · filed 2025-11-14
2024-06-30555.00K shares
10-Q · filed 2025-08-14
2024-03-31558.00K shares
10-Q · filed 2025-05-15
2023-12-31569.00K shares
10-K · filed 2025-03-31
2023-09-30572.00K shares
10-Q · filed 2024-11-13
2023-06-30363.00K shares
10-Q · filed 2024-08-14
2023-03-31363.00K shares
10-Q · filed 2024-05-13
2022-12-31363.00K shares
10-K · filed 2024-03-28
2022-09-30370.00K shares
10-Q · filed 2023-11-13
2022-06-302.58M shares
10-Q · filed 2023-08-14
2022-03-31226.00K shares
10-Q · filed 2023-05-15		2.71M shares
10-Q · filed 2022-05-11
2021-12-31226.00K shares
10-K · filed 2023-03-29		2.72M shares
10-K · filed 2022-03-23
2021-09-30226.00K shares
10-Q · filed 2022-11-14
2021-06-301.68M shares
10-Q · filed 2022-08-15
2021-03-312.02M shares
10-Q · filed 2022-05-11		2.02M shares
10-Q · filed 2021-05-17
2020-12-312.02M shares
10-K · filed 2022-03-23
2020-09-302.04M shares
10-Q · filed 2020-11-13
2020-06-302.04M shares
10-Q · filed 2021-08-16
2020-03-311.17M shares
10-Q · filed 2021-05-17
2019-12-311.17M shares
10-K · filed 2021-03-17		1.17M shares
10-K · filed 2020-03-27
2019-09-301.17M shares
10-Q · filed 2020-11-13
2019-06-301.23M shares
10-Q · filed 2019-08-09		1.23M shares
10-Q · filed 2020-08-06		1.21M shares
10-Q · filed 2019-08-09
2019-03-311.42M shares
10-Q · filed 2020-05-13
2018-12-311.59M shares
10-K · filed 2020-03-27
2018-09-301.59M shares
10-Q · filed 2018-11-09		1.59M shares
10-Q · filed 2018-11-09
2018-06-30669.00K shares
10-Q · filed 2019-08-09		669.00K shares
10-Q · filed 2019-08-09
2018-03-31882.00K shares
10-Q · filed 2019-05-10
2017-12-311.04M shares
10-K · filed 2019-04-01
2017-09-3027.62M shares
10-Q · filed 2018-11-09		27.62M shares
10-Q · filed 2018-11-09
2017-06-30977.00K shares
10-Q · filed 2018-08-09		29.33M shares
10-Q · filed 2017-08-08		977.00K shares
10-Q · filed 2018-08-09		29.33M shares
10-Q · filed 2017-08-08
2017-03-31988.00K shares
10-Q · filed 2018-05-10		23.38M shares
10-Q · filed 2017-05-10
2016-12-31812.00K shares
10-K · filed 2018-03-21		24.35M shares
10-K · filed 2017-03-31
2016-09-3024.65M shares
10-Q · filed 2017-11-08		25.43M shares
10-Q · filed 2017-11-08
2016-06-3044.40M shares
10-Q · filed 2017-08-08		44.40K shares
10-Q · filed 2016-08-09		44.30K shares
10-Q · filed 2017-08-08
2016-03-3143.05M shares
10-Q · filed 2017-05-10		43.05K shares
10-Q · filed 2016-05-10
2015-12-311.71M shares
10-K · filed 2018-03-21		51.45K shares
10-K · filed 2016-03-15
2015-09-3027.18M shares
10-Q · filed 2016-11-09		24.61M shares
10-Q · filed 2015-11-16		24.61M shares
10-Q · filed 2016-11-09		27.42M shares
10-Q · filed 2015-11-16
2015-06-3027.24K shares
10-Q · filed 2016-08-09		27.24M shares
10-Q · filed 2015-08-14		31.79K shares
10-Q · filed 2016-08-09		31.79M shares
10-Q · filed 2015-08-14
2015-03-3133.82K shares
10-Q · filed 2016-05-10		12.60K shares
10-Q · filed 2015-05-14
2014-12-3136.27K shares
10-K · filed 2017-03-31
2014-09-3029.73M shares
10-Q · filed 2015-11-16		29.73K shares
10-Q · filed 2014-11-14		3.06M shares
10-Q · filed 2015-11-16		27.63K shares
10-Q · filed 2014-11-14
2014-06-3030.52M shares
10-Q · filed 2015-08-14		30.52K shares
10-Q · filed 2014-08-14		30.52M shares
10-Q · filed 2015-08-14		30.52K shares
10-Q · filed 2014-08-14
2014-03-3130.93K shares
10-Q · filed 2015-05-14		30.82K shares
10-Q · filed 2014-05-15
2013-09-3029.73K shares
10-Q · filed 2014-11-14		27.63K shares
10-Q · filed 2014-11-14
2013-06-3017.63K shares
10-Q · filed 2014-08-14		17.63K shares
10-Q · filed 2014-08-14
2013-03-3115.31K shares
10-Q · filed 2014-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Rocket One Inc. (RKTO)United States$0.019B
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
Advertisement